Memphis-based biopharmaceutical company GTx Inc. swung to a loss for the third quarter compared to the year-ago period, the company reported this week.

2. GTx Reports $6.9 Million Loss in Third Quarter - Friday, November 4, 2016

Memphis-based biopharmaceutical company GTx Inc. swung to a loss for the third quarter compared to the year-ago period, the company reported this week.

3. GTx Reports Second-Quarter Loss - Friday, August 7, 2015

Memphis-based biopharmaceutical company GTx Inc. reported a net loss of $48 million in the second quarter, wider than its $10.9 million net loss in second quarter 2014.

4. GTx Names New Medical Director - Saturday, July 11, 2015

Dr. Diane C. Young is the new vice president, chief medical officer, of GTx Inc.

The Memphis-based biopharmaceutical company announced Young’s appointment Wednesday, July 8.

5. GTx Names New Medical Director - Thursday, July 9, 2015

Dr. Diane C. Young is the new vice president, chief medical officer, of GTx Inc.

The Memphis-based biopharmaceutical company announced Young’s appointment Wednesday, July 8.

6. GTx Reports Full-Year, Fourth-Quarter Loss - Thursday, March 5, 2015

Memphis-based biopharmaceutical company GTx Inc. has reported a net loss of $14.5 million for the quarter ended Dec. 31 and an annual net loss of $39.4 million for 2014.

7. Johnson & Johnson Exec Named GTx Chairman - Saturday, February 21, 2015

Memphis-based GTx has a new chairman – Dr. Robert Wills, who’s joining effective March 2 after retiring from Johnson & Johnson.

8. GTx Taps Johnson & Johnson Executive as New Chairman - Thursday, February 19, 2015

GTx has a new chairman: Dr. Robert Wills, who’s joining effective March 2 after retiring from Johnson & Johnson.

9. Steiner Resigns as CEO of GTx - Friday, April 4, 2014

Dr. Mitchell Steiner has resigned effective Thursday from being CEO and vice chairman of GTx, the Memphis-based company he co-founded.

10. GTx Layoffs Show Drug Market’s Volatility - Thursday, October 3, 2013

The layoffs at Memphis-based GTx Inc., announced Tuesday, Oct. 1, came with the resignation of the drug manufacturing company’s chief financial officer and pay cuts for GTx’s top three leaders.

11. Cousins Join Forces as Rosenblum & Reisman Law Firm - Monday, August 12, 2013

As the law firm of Rosenblum & Reisman celebrates its 15th year in business, it is with the knowledge and a sense of accomplishment that clients have been treated with the utmost respect, and that fellow lawyers and staff are treated as family. Indeed, the principals, Jeff Rosenblum and Marc Reisman, are first cousins.

12. Steiner, GTx Inc. Prepare For Next Step of Journey - Monday, April 16, 2012

Dr. Mitchell Steiner recently returned from a trip to Eastern Europe, where he visited hospitals participating in international clinical trials for the drug enobosarm, which is being developed by his Memphis-based public biopharmaceutical company GTx Inc.

13. Many Questions Raised Before Going Public - Monday, April 16, 2012

As Facebook prepares for its multibillion-dollar initial public offering (IPO) next month, it sheds light on how companies – including local ones – decide whether to go public or not.

Memphis-based pharmaceutical company GTx Inc. went public in 2004 and local paper producer Verso Paper Corp. held its IPO in 2008, but the overall number of publicly traded companies both locally and nationally has dropped over the past two decades.

14. GTx’s Loss Widens on News of Abandoned Drug - Tuesday, August 10, 2010

The write-off of investments related to the development of a drug that didn’t pan out caused GTx Inc. to have a bigger loss during the second quarter.

15. GTx’s Loss Widens on News of Abandoned Drug - Monday, August 9, 2010

The write-off of investments related to the development of a drug that didn’t pan out caused GTx Inc. to have a bigger loss during the second quarter.

16. Powerful Possibilities - Monday, May 17, 2010

Oct. 29 turned into a day for window staring when the news came.

The top executives of GTx Inc. looked at the bleak gray of an overcast sky from the seventh floor of the Toyota Center, their minds gone blank.

17. GTx Reports $44.3M Net Income - Wednesday, May 5, 2010

GTx Inc. is pressing ahead with the development of a drug for muscle wasting in cancer patients after ending its partnership with Merck.

18. GTx, Merck Part Ways - Tuesday, March 16, 2010

Memphis-based GTx Inc. has ended its partnership with Merck & Co. to develop a drug to prevent wasting and muscle loss in cancer patients.

19. Influence 1 Foundation Names Hartsfield COO - Wednesday, February 11, 2009

Felicia Hartsfield has been named chief operating officer of Influence 1 Foundation.

Hartsfield will oversee the continued stability and growth of the foundation’s fiscal, strategic, organizational and operational functions. Her duties also will include building and maintaining relationships with community leaders, as well as creating collaborations, which will enhance the foundation’s strategic model.

20. GTx Outlines Drug Pipeline - Friday, November 7, 2008

Executives at Memphis-based GTx on Thursday morning explained a promising pipeline of potential drug therapies that are moving closer to FDA approval and attracting investment partnerships from big pharmaceutical companies.

21. Burford to Help Develop PR Efforts For Memphis Area Teachers' Credit Union - Wednesday, June 14, 2006

Marc Burford has been promoted to business development coordinator at Memphis Area Teachers' Credit Union (MATCU). In his new role, Burford will be responsible for helping develop public relations and for coordinating various public functions that promote MATCU's products and services. He started working at MATCU in 2003 as a sales associate and was promoted to an assistant branch manager in 2004.